Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease.

Dong B, Chen Y, He F, Li B, Wu B, Chen Z, Zhao E, Chen Y, Zhang C

Open source

DOI
10.1186/s12933-026-03294-x
Published
2026 Jul 17
Container
Cardiovascular diabetology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12933-026-03294-x,
  title = {Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease.},
  author = {Dong B and Chen Y and He F and Li B and Wu B and Chen Z and Zhao E and Chen Y and Zhang C},
  year = {2026},
  journal = {Cardiovascular diabetology},
  doi = {10.1186/s12933-026-03294-x},
  url = {https://doi.org/10.1186/s12933-026-03294-x}
}

RIS

TY  - JOUR
TI  - Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease.
AU  - Dong B
AU  - Chen Y
AU  - He F
AU  - Li B
AU  - Wu B
AU  - Chen Z
AU  - Zhao E
AU  - Chen Y
AU  - Zhang C
PY  - 2026
JO  - Cardiovascular diabetology
DO  - 10.1186/s12933-026-03294-x
UR  - https://doi.org/10.1186/s12933-026-03294-x
ER  - 

APA

B, D., Y, C., F, H., B, L., B, W., Z, C., E, Z., Y, C., & C, Z. (2026). Lipoprotein(a), insulin resistance, and cardiovascular outcomes in metabolic dysfunction-associated steatotic liver disease.. Cardiovascular diabetology. https://doi.org/10.1186/s12933-026-03294-x

Source records